215 related articles for article (PubMed ID: 6101993)
1. Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens.
Tsuda H; Lee G; Farber E
Cancer Res; 1980 Apr; 40(4):1157-64. PubMed ID: 6101993
[TBL] [Abstract][Full Text] [Related]
2. The slow induction of resistant hepatocytes during initiation of hepatocarcinogenesis by the nongenotoxic carcinogen clofibrate.
Nagai MK; Farber E
Exp Mol Pathol; 1999 Dec; 67(3):144-9. PubMed ID: 10600397
[TBL] [Abstract][Full Text] [Related]
3. Persistence of resistant putative preneoplastic hepatocytes induced by N-nitrosodiethylamine or N-methyl-N-nitrosourea.
Solt DB; Cayama E; Sarma DS; Farber E
Cancer Res; 1980 Apr; 40(4):1112-8. PubMed ID: 7357542
[TBL] [Abstract][Full Text] [Related]
4. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures.
Columbano A; Rajalakshmi S; Sarma DS
Cancer Res; 1981 Jun; 41(6):2079-83. PubMed ID: 6113048
[TBL] [Abstract][Full Text] [Related]
5. Role of acute hepatic necrosis in the induction of early steps in liver carcinogenesis by diethylnitrosamine.
Ying TS; Sarma DS; Farber E
Cancer Res; 1981 Jun; 41(6):2096-102. PubMed ID: 6113050
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats.
Carr BI
Cancer Res; 1987 Nov; 47(21):5577-83. PubMed ID: 2889526
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle kinetics of rat hepatocytes in early putative preneoplastic lesions in hepatocarcinogenesis.
Rotstein J; Macdonald PD; Rabes HM; Farber E
Cancer Res; 1984 Jul; 44(7):2913-7. PubMed ID: 6144384
[TBL] [Abstract][Full Text] [Related]
8. Effects of delays in the cell cycle on the induction of preneoplastic and neoplastic lesions in rat liver by 1,2-dimethylhydrazine.
Ying TS; Enomoto K; Sarma DS; Farber E
Cancer Res; 1982 Mar; 42(3):876-80. PubMed ID: 7059985
[TBL] [Abstract][Full Text] [Related]
9. Low selection of preneoplastic hepatocytes after treatment with the 2-acetylaminofluorene diet-partial hepatectomy regimen in the liver of hepatocarcinogenesis-resistant DRH strain rats.
Imai K; Yamamoto M; Tanaka H; Hashimoto N; Miyakoshi M; Honmou S; Yoshie M; Tamakawa S; Yaginuma Y; Kasai S; Ogawa K
Oncol Rep; 2007 Jan; 17(1):55-60. PubMed ID: 17143478
[TBL] [Abstract][Full Text] [Related]
10. Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model.
Chakraborty T; Chatterjee A; Saralaya MG; Dhachinamoorthi D; Chatterjee M
Life Sci; 2006 May; 78(24):2839-51. PubMed ID: 16352317
[TBL] [Abstract][Full Text] [Related]
11. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
[TBL] [Abstract][Full Text] [Related]
12. The effect of caffeic acid phenethyl ester analogues in a modified resistant hepatocyte model.
Macías-Pérez JR; Beltrán-Ramírez O; Vásquez-Garzón VR; Salcido-Neyoy ME; Martínez-Soriano PA; Ruiz-Sánchez MB; Angeles E; Villa-Treviño S
Anticancer Drugs; 2013 Apr; 24(4):394-405. PubMed ID: 23388162
[TBL] [Abstract][Full Text] [Related]
13. Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis.
Cameron R; Kellen J; Kolin A; Malkin A; Farber E
Cancer Res; 1978 Mar; 38(3):823-9. PubMed ID: 23897
[TBL] [Abstract][Full Text] [Related]
14. Transfer of viable putative preneoplastic hepatocytes to the livers of syngeneic host rats.
Laishes BA; Farber E
J Natl Cancer Inst; 1978 Aug; 61(2):507-12. PubMed ID: 28422
[TBL] [Abstract][Full Text] [Related]
15. Gamma glutamyl transpeptidase in safrole-induced, presumptive premalignant mouse hepatocytes.
Lipsky MM; Hinton DE; Klaunig JE; Goldblatt PJ; Trump BF
Carcinogenesis; 1980 Feb; 1(2):151-6. PubMed ID: 22282994
[TBL] [Abstract][Full Text] [Related]
16. A novel in vitro-in vivo approach to carcinogenesis studies designed for use with human cells and tissues.
Cameron RG; Eriksson LC; Lee G
Acta Cytol; 1984; 28(5):614-20. PubMed ID: 6592924
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the development of rat liver preneoplastic lesions by verapamil and dexverapamil.
Ghia M; Mereto E; Cavanna M; Brambilla G
Anticancer Res; 1996; 16(4A):1739-41. PubMed ID: 8712693
[TBL] [Abstract][Full Text] [Related]
18. Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens.
Columbano A; Ledda-Columbano GM; Lee G; Rajalakshmi S; Sarma DS
Cancer Res; 1987 Nov; 47(21):5557-9. PubMed ID: 2889525
[TBL] [Abstract][Full Text] [Related]
19. Early initiating and promoting effects in 2-AAF-induced rat liver carcinogenesis: an immunohistochemical study.
Hadjiolov N; Bitsch A; Neumann HG
Cancer Lett; 1995 Nov; 98(1):39-46. PubMed ID: 8529204
[TBL] [Abstract][Full Text] [Related]
20. [Stimulation, by acute inflammation, of the proliferation in preneoplastic hepatocyte foci expressing the gamma glutamyl transpeptidase, induced by diethylnitrosamine in adult rats].
Nadal C; Valéro D; Périn F
C R Acad Sci III; 1988; 307(5):239-44. PubMed ID: 2903788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
